Full-Time

Global Marketing Mix Optimization Lead

m/f

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Morristown, NJ, USA

Category
General Marketing
Growth Marketing
Growth & Marketing
Required Skills
Agile
Data Science
JIRA
Confluence
Data Analysis
Requirements
  • BS degree or higher (or equivalent); Masters degree in a quantitative discipline (e.g., data science, statistics, applied mathematics, or economics) is preferred
  • Prior experience in analytics ideally marketing mix modelling and exposure/influence of top executive
  • Knowledge of advanced statistics, data science, web-based design, agile (Jira/Confluence)
  • Leadership & business ownership
  • Influence & story-telling
  • Collaboration & agile
  • Technical & business fluency
  • Data-driven culture
  • Rigor
  • Fluent in English
Responsibilities
  • Influencing executive leadership team up to CEO/CFO on A&P investment decisions
  • Responsible for delivering ROI increase target year-on-year
  • Setting up and executing the program vision to optimize A&P spend (MMM, trigger models, A/B testing)
  • Defining the governance & process
  • Ensuring visibility of the overall capability internally and externally
  • Coordinating large technical teams and business teams across functions & geographies
  • Interpreting correctly analytics output and bring agility for optimal forward looking decisions
  • Transferring newly built A&P capability to local and regional business teams in 15+ markets
  • Collecting user feedbacks to continuously enhance WebApp User Experience
  • Removing roadblocks to deliver on-time
  • Continuously performing quality checks on data & advanced models
  • Managing direct (internal & external) and indirect reports

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse pipeline of new products. The company's goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?